Site Map   © All Right Reserved. AHSCT RUSSIA, Moscow 2020.
Application
Admission
SiteMap
Application
Admission
SiteMap
SiteMap
Navigation through pages https://hsct-russia.com/
GENERAL INFORMATION
General Information
What is HSCT
General information about HSCT treatment for Patients with Multiple Sclerosis
Stages of Treatment
Stages of HSCT
Description of HSCT treatment stages in Moscow Hospital, Russia.
General Advantages
Advantages
Advantages of HSCT Treatment for Multiple Sclerosis Patients in Moscow, Russia.
Health Limitations
Eligibility Criteria
A list of underlying medical conditions for HSCT treatment of autoimmune diseases
Medications cancellation
Before Treatment
Patient should stop taking immunomodulating drugs in 3-6 months before admission
Questionnaire
Application for MS
The following questionnaire is required to define whether HSCT is a meaningful and safe treatment option.
CIDP Questionnaire
CIDP Application form
The following questionnaire is required to define whether HSCT is a meaningful and safe treatment option.
RESEARCH
Revelant pages
Clinical Outcomes
Clinical Outcomes
Clinical and Patient-Reported Outcomes of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) In Patients with Multiple Sclerosis: (Mainly focused on SPMS, RRMS) Single Center Experience
Low-Intensity conditioning
Low-Intensity conditioning
Autologous hematopoietic stem cell transplantation with low-intensity conditioning regimens in relapsing remitting multiple sclerosis: clinical outcomes and quality of life
New conditioning for RRMS
New conditioning for RRMS
Intermediate-Intensity Chemotherapy (IDCT) + AHSCT for patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
HSCT vs DMT
HSCT vs DMT
Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis
Dr. Denis Fedorenko
Dr. Denis Fedorenko
The Leading Hematologist of Russia, Doctor of Medical Sciences, Professor of the Department of Hematology and Cellular Therapy
Medical correspondence
Questions from our Patients
This page contain interesting questions and qualified answers. Reliable conversation in an impersonal form. Use the search box to navigate the content.
Dr. Denis Fedorenko
Dr. Denis Fedorenko
The Leading Hematologist of Russia, Doctor of Medical Sciences, Professor of the Department of Hematology and Cellular Therapy
Medical correspondence
Questions from our Patients
This page contain interesting questions and qualified answers. Reliable conversation in an impersonal form. Use the search box to navigate the content.
HSCT vs DMT
HSCT vs DMT
Indications and Efficacy of Disease-Modifying Therapies and Supportive Care of Multiple Sclerosis
Research Article 2025
Research Article 2025
Research Article: Acta Scientific Neurology (ASNE) Volume 8 Issue 11 November 2025
(Chicago)
Richard Burt
HSCT for Severe AD: History, Progress and Perspectives
(Berlin)
Alexander Tobias
Immunological Reconstitution after AHSCT in AD
(Moscow)
Denis Fedorenko
Modern Concept of HSCT for AID
(St.Petersburg)
Gennady Bisaga
Treatment Modalities for MS
(Florence)
Riccardo Saccardi
AHSCT in MS: EBMT Experience
(Minsk)
Andreeva Marina
HSCT for MS in Belarus
(Uppsala)
Joachim Burman
AHSCT for Neurological Diseases
(Moscow)
Kirill Kirgizov
AHSCT in Pediatric Neurological AD
(St.Petersburg)
Alexey Polushin
Outcomes of AHSCT in MS: Experience of RGMI of Child Hematology and Transplantation
(Hanoi)
Liem Nguyen Thanh
Outcomes of BMMNCT for Cerebral Palsy and Autism
(St.Petersburg)
Tatyana Ionova
A.Novik Memorial Lecture 
(Moscow) 
Sergey Lukianov
A new strategy for the treatment of AD
(Moscow) 
Alexander Lila
Treatment modalities for Systemic Sclerosis
(Paris)
Dominique Farge
AHSCT in SSc: EBMT experience & what is the next step?
(Milan) 
Nicoletta Del Papa
SSc screening and patient selection for AHSCT
(Saint-Petersburg)
Maria Khrabrova
SLE and Systemic Sclerosis
(New Jersey)
Gary Gorodokin
Treatment modalities for Crohn's Disease
(Sheffield)
John Snowden
AHSCT for Crohn's Disease and other AD:  EBMT Experience
(Moscow)
Anna Roppelt
HSCT as a Curative Option of Monogenic Forms of Inflammatory Bowel Disease 
SCHEDULED PATIENTS
Revelant pages
Contract & Payment
Contract and Payment information for the patients of the Moscow multidisciplinary Hospital
Visa Support
Information about the procedure of obtaining a visa to Russia for patients, his family members, caregivers and accompanying persons.
Transfer Application
Arrival Transfer
This application is used to provide details about your arrival & departure. Please, don't forget to complete it, regardless of whether you've already sent your e-tickets to hospital administrator or not.
Send files to profile
Uploader form
Submit files to the personal profile of the patient or visitors of the hospital (signed agreement, statements, e-tickets, residence permit, visa copy and other files)
Create a profile
Registration Form
Unified registration form required to create a profile of the patient and his visitors (details for visa invitation, contract, payment and other legal papers)
Travel voucher-confirmation
Completing an Application for Visa at the specialised website of the Consular department of the Ministry of Foreign Affairs of the Russian Federation
Invitation from Hospital
Completing an Application for Visa at the website of the Consulate using the details of your Invitation from the Hospital
E-FMS Invitation
Completing an Application for Visa at the specialised website of the Consular department of the Ministry of Foreign Affairs of the Russian Federation
Telex Invitation
Completing an Application for Visa at the specialised website of the Consular department of the Ministry of Foreign Affairs of the Russian Federation
DISCHARGED
Revelant pages
Online questionnaire
Follow-Up Form
The following questionnaire is required to define your condition after HSCT Treatment without visiting the Hospital
Registration form
Annual Check-up
Annual Check-up in the Hospital for Patients who underwent HSCT treatment in Moscow, Russia
E-mail
Website home page
Facebook page
Community group
YouTube channel
Instagram page
Twitter page